CAR T CELL
Clinical trials for CAR T CELL explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL trials appear
Sign up with your email to follow new studies for CAR T CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a One-Time cell treatment tame lupus in young patients?
Disease control Recruiting nowThis study tests a new treatment called CART19 for teens and young adults (ages 12-29) with severe lupus that hasn't improved with standard treatments. CART19 uses a patient's own immune cells, modified in a lab to target and calm the overactive immune system causing lupus. The g…
Matched conditions: CAR T CELL
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene therapy patients monitored for 15 years in new safety study
Knowledge-focused Recruiting nowThis study follows up to 500 people who have received a gene therapy product from Seattle Children's Hospital. Researchers will track participants for 15 years to watch for any delayed side effects and see how long the therapy lasts in the body. No new treatment is given—this is …
Matched conditions: CAR T CELL
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
CAR-T cell therapy: hidden heart risks?
Knowledge-focused Recruiting nowThis study looks at whether CAR-T cell therapy, a new immunotherapy for blood cancers like leukemia and lymphoma, can cause early heart problems. Researchers will measure heart function with ultrasound before and a few days after treatment in 60 patients. The goal is to find out …
Matched conditions: CAR T CELL
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:33 UTC